As I said, we've done a couple of studies.
On one of the things we did, again, as far as I know—and I've now been in this job for the last six years and I have a pretty good handle on it internationally—we're one of the only countries that has had a benefit measurement framework.
Not only have we taken these reports and said it's $6 billion and $7 billion—and we've heard it could be higher—but we wanted to put in place a benefit mechanism that asks whether we are getting those benefits.
We brought in some of the brightest minds from the research community, some of the international guys, and a lot of our guys in Canada. They designed a framework for us that has a variety of indicators. As we fund projects and these projects come on line, we then go back and systematically measure whether those benefits have been achieved.
I've talked about diagnostic imaging. We're about to publish one on drugs. For even the few provinces that we have, we're looking at benefits in the region of about $450 million a year. When you extrapolate that, it's well over $1 billion a year for Canadians. There are big benefits.
Again, as some of the other systems come on board, we'll be doing the same type of measurement work.